Nearly 16 million Americans have the most deadly type of liver disease - metabolic dysfunction-associated steatohepatitis ...

Jim Gaffigan doesn’t want any credit for his 50-lb weight loss — no, seriously. While speaking to Today hosts Jenna Bush Hager and Justin Sylvester on Monday, May 26, Gaffigan explained he ...

Of all the aminos tested, knocking out cysteine led to rapid and drastic weight loss, reducing some of the rodents' body weights by 30% in just seven days. The reason for the result was that when ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...

sought to measure weight gain after stopping the use of weight loss medication, or GLP-1 receptor agonists. Researchers determined that ceasing older weight loss medications resulted in a return ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. By Rebecca Robbins Novo Nordisk will replace its ...

I have finally found some success with the new GLP-1 weight loss drugs. Will it stick? Who knows. But I have lost 20 pounds so far and am feeling better than I have in a decade. And I am hopeful ...

The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

For this article, we define “strongest” as the medication associated with the highest percentage of body weight loss. Phentermine-topiramate (Qsymia) is a combination medication that’s ...

Kayla Girgen, RD, is a licensed dietitian who specializes in weight management and weight loss for patients after bariatric surgery. Water is the most abundant component in the body and is ...

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping obesity treatment strategies and offering new hope for patients ...